Actively Recruiting
Intensive Cancer Screening After Cryptogenic Stroke
Led by Ottawa Hospital Research Institute · Updated on 2025-07-31
45
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
Sponsors
O
Ottawa Hospital Research Institute
Lead Sponsor
B
Brain Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
The INCOGNITO Pilot Trial is a single centre pilot prospective randomized open-label blinded endpoint (PROBE) trial to assess the feasibility of a full-scale randomized trial to determine whether an occult cancer screening strategy of FDG PET/CT (F-fluorodeoxyglucose positron emission/computed tomography) in addition to usual care increases the number of occult cancers diagnosed after screening compared to usual care cancer screening alone in patients with cryptogenic stroke.
CONDITIONS
Official Title
Intensive Cancer Screening After Cryptogenic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Presenting to the Ottawa Hospital Stroke Prevention Clinic or Neurovascular Unit with a first cryptogenic ischemic stroke after advanced evaluation within 3 months
- Patient or delegate willing and able to provide informed consent
You will not qualify if you...
- Contraindications to FDG PET/CT such as pregnancy or inability to lie still for 20 minutes
- Active cancer or previous cancer diagnosis except basal or squamous cell carcinoma of the skin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9
Actively Recruiting
Research Team
D
Dariush Dowlatshahi, MD PhD
CONTACT
D
Deborah Siegal, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here